Tumor progression and oxidant-antioxidant status

Area of Science:

• Oncology
• Biochemistry
• Nutritional Science

Background:

• Previous research indicated a paradoxical oxidant-antioxidant imbalance in breast cancer patients.
• This imbalance was noted to be more pronounced in pre-menopausal women than in menopausal women.

Purpose of the Study:

• To investigate the relationship between tumor progression and oxidant-antioxidant status in cancer patients.
• To explore differences in oxidant-antioxidant status between young pre-menopausal and aged menopausal breast cancer patients based on prognostic factors.

Main Methods:

• Measurements of Vitamin E/total cholesterol and plasma malondialdehyde were conducted.
• Analysis included 146 patients with various carcinomas and a separate cohort of 365 breast cancer patients.
• Data were analyzed based on tumor size, progression, pathology, and estrogen receptor status.

Main Results:

• Vitamin E/total cholesterol levels increased, while plasma malondialdehyde decreased as tumor size and progression advanced.
• The observed oxidant-antioxidant status patterns correlated with prognostic factors like pathology, tumor size, and estrogen receptors.
• These variations were more pronounced in younger pre-menopausal women than in aged menopausal women.

Conclusions:

• The oxidant-antioxidant status in breast cancer patients is linked to tumor progression and specific prognostic factors.
• Younger pre-menopausal women exhibit a more pronounced oxidant-antioxidant imbalance compared to older menopausal women.
• These findings highlight age and menopausal status as critical factors influencing oxidative stress in breast cancer.